Aspirin Linked to Lower Risk of Liver Cancer


November 30, 2012

ABC News - Aspirin and other nonsteroidal anti-inflammatory drugs or NSAIDS may help prevent serious liver disease including cancer, new study found.

Aspirin users were 41 percent less likely to develop liver cancer and 45 percent less likely to die from chronic liver disease than non-users, according to study author Vikrant Sahasrabuddhe of the National Cancer Institute in Rockville, Md., and colleagues.

Other NSAIDs were also linked to a lower risk of death from chronic liver disease, but not with less liver cancer, according to the study of more than 300,000 middle-age and older adults.

A new study by researchers at the U.S. National Cancer Institute found that staying physically active after age 40 seems to increase your lifespan between two and seven years. And the more you exercise, the longer your life expectancy -- regardless of your weight.

See more at ABC News